Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Cancer Biology
  • View item
  • Home
  • ICR Divisions
  • Cancer Biology
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

First report on the reliability and validity of speech handicap index in native English-speaking patients with head and neck cancer.

Thumbnail
Date
2011-03
ICR Author
Nutting, Chris
Roe, Justin
Harrington, Kevin
Author
Dwivedi, RC
St Rose, S
Roe, JWG
Chisholm, E
Elmiyeh, B
Nutting, CM
Clarke, PM
Kerawala, CJ
Rhys-Evans, PH
Harrington, KJ
Kazi, R
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
Background Posttreatment speech problems are seen in nearly half of patients with head and neck cancer. Although there are many voice-specific scales, surprisingly there is no speech-specific questionnaire for English-speaking patients with head and neck cancer. The aim of this study was to validate the Speech Handicap Index (SHI) as the first speech-specific questionnaire in the English language.Method In all, 55 consecutive patients in follow-up for oral and oropharyngeal cancer completed the SHI and University of Washington Quality of Life Questionnaire (UWQOL V.04). Thirty-two patients completed both questionnaires again 4 weeks later to address test-retest reliability.Results Internal consistency, test-retest reliability, construct validity, and group validity of the SHI were found to be highly significant (p < .01) using Cronbach's alpha, Spearman's correlation coefficient (r), and Mann-Whitney U tests.Conclusions The SHI is a precise, highly reliable, and valid speech assessment tool for patients with head and neck cancer. Further dedicated studies using the SHI in patients with head and neck cancer would be useful.
URI
https://repository.icr.ac.uk/handle/internal/1731
DOI
https://doi.org/10.1002/hed.21450
Collections
  • Cancer Biology
  • Radiotherapy and Imaging
Subject
Humans
Head and Neck Neoplasms
Mouth Neoplasms
Oropharyngeal Neoplasms
Speech Disorders
Disability Evaluation
Severity of Illness Index
Incidence
Cohort Studies
Follow-Up Studies
Reproducibility of Results
Language
Causality
Comorbidity
Age Distribution
Sex Distribution
Quality of Life
Adult
Aged
Aged, 80 and over
Middle Aged
Disabled Persons
Female
Male
Surveys and Questionnaires
Research team
Targeted Therapy
Language
eng
License start date
2011-03
Citation
Head & neck, 2011, 33 (3), pp. 341 - 348

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.